PMID- 34210318 OWN - NLM STAT- MEDLINE DCOM- 20220125 LR - 20240402 IS - 1472-6823 (Electronic) IS - 1472-6823 (Linking) VI - 21 IP - 1 DP - 2021 Jul 1 TI - Interactions between Caveolin-1 (rs3807992) polymorphism and major dietary patterns on cardio-metabolic risk factors among obese and overweight women. PG - 138 LID - 10.1186/s12902-021-00800-y [doi] LID - 138 AB - BACKGROUND: Caveolin-1 (CAV-1) is a cholesterol-dependent essential component located in caveolae. Several studies have been CAV-1 related to cardio-metabolic parameters in animal models, however, there are few studies in humans. Importantly, there is no study has investigated the interaction between CAV-1 rs3807992 gene and dietary patterns (DPs) on cardio-metabolic risk factors. METHODS: The current cross-sectional study was conducted on 404 overweight and obese women. Dietary intake was obtained from FFQ with 147 items. The CAV-1 genotype was measured by the PCR-RFLP method. The anthropometric measurements, serum lipid profile, and inflammatory markers were measured by standard protocols. RESULTS: There was a significant interaction between CAV-1 rs3807992 and healthy DP on high-density cholesterol (HDL) (P-interaction = 0.03), TC/HDL (P-interaction = 0.03) and high sensitivity C-reactive protein (hs-CRP) (P-interaction = 0.04); in A-allele carriers, higher following a healthy DP was related to a higher level of HDL and lower TC/HDL and hs-CRP. As well as, the significant interactions were observed between CAV-1 rs3807992 and unhealthy DP in relation to triglyceride (TG) (P-interaction = 0.001), aspartate aminotransferase (AST) (P-interaction = 0.01) and monocyte chemoattractant protein-1(MCP-1) (P-interaction = 0.01); A-allele carriers were more following the unhealthy DP had lower levels of TG, AST and MCP-1. CONCLUSIONS: Our study revealed a significant gene-diet interaction between rs3807992 SNPs and DPs in relation to cardio-metabolic risk factors; A-allele carriers might be more sensitive to dietary composition compared to GG homozygotes. Following a healthy DP in A-allele-carriers may be improved their genetic association with cardio-metabolic risk factors. FAU - Abaj, Faezeh AU - Abaj F AD - Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran. FAU - Koohdani, Fariba AU - Koohdani F AD - Department of Cellular, Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran. FAU - Rafiee, Masoumeh AU - Rafiee M AD - Department of Clinical Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences (IUMS), Isfahan, Iran. FAU - Alvandi, Ehsan AU - Alvandi E AD - School of Medicine, Western Sydney University, Campbelltown, NSW 2560, Australia. FAU - Yekaninejad, Mir Saeed AU - Yekaninejad MS AD - Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences (TUMS), Tehran, Iran. FAU - Mirzaei, Khadijeh AU - Mirzaei K AD - Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences (TUMS), Tehran, Iran. mirzaei_kh@tums.ac.ir. LA - eng PT - Journal Article DEP - 20210701 PL - England TA - BMC Endocr Disord JT - BMC endocrine disorders JID - 101088676 RN - 0 (CAV1 protein, human) RN - 0 (Caveolin 1) RN - 0 (Triglycerides) RN - 97C5T2UQ7J (Cholesterol) SB - IM MH - Adult MH - *Cardiometabolic Risk Factors MH - Caveolin 1/*genetics MH - Cholesterol/blood MH - Cross-Sectional Studies MH - Diet/*adverse effects MH - Diet Surveys MH - Female MH - *Gene-Environment Interaction MH - Genotype MH - Humans MH - Middle Aged MH - Obesity/*genetics MH - Overweight/*genetics MH - Polymorphism, Single Nucleotide/*genetics MH - Triglycerides/blood PMC - PMC8247154 OTO - NOTNLM OT - Cardio-metabolic OT - Caveolin-1 OT - Diet OT - Gene-environment interaction OT - Personalized diet OT - Polymorphism COIS- The authors declare no conflict of interest. EDAT- 2021/07/03 06:00 MHDA- 2022/01/27 06:00 PMCR- 2021/07/01 CRDT- 2021/07/02 05:37 PHST- 2020/11/01 00:00 [received] PHST- 2021/06/19 00:00 [accepted] PHST- 2021/07/02 05:37 [entrez] PHST- 2021/07/03 06:00 [pubmed] PHST- 2022/01/27 06:00 [medline] PHST- 2021/07/01 00:00 [pmc-release] AID - 10.1186/s12902-021-00800-y [pii] AID - 800 [pii] AID - 10.1186/s12902-021-00800-y [doi] PST - epublish SO - BMC Endocr Disord. 2021 Jul 1;21(1):138. doi: 10.1186/s12902-021-00800-y.